Literature DB >> 32065448

Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.

Wenbo Zhao1, Shuai Wang1, Tingyu Qin1, Wenzhan Wang1.   

Abstract

It is growingly recognized that messenger RNAs (mRNAs) are important regulators of various cancers. However, there are few reporters about the function of E2F3 in retinoblastoma (RB), which needs more exploration. In addition, the circRNA circ-0075804 was derived from the E2F3 host gene. The purpose of the study is to figure out the role and molecular regulation mechanism of E2F3 and circ-0075804 in RB. The role of E2F3 in RB was determined through E2F3 silencing and loss of expression was evaluated by real-time quantitative polymerase chain reaction (RT-qPCR), Western blot, CCK-8, colony formation, and 5-ethynyl-2'-deoxyuridine assays. The interactions between E2F3 and circ-0075804 were validated through loss and gain function of circ-0075804. Besides, the role of circ-0075804 in RB was determined by several functional assays. And the binding ability between heterogeneous nuclear ribonucleoprotein K and circ-0075804 was verified by RNA pull-down, Western blot, and RT-qPCR assays. The expression of E2F3 was upregulated in RB cell lines. Furthermore, knockdown of E2F3 inhibited cell proliferation and induced cell apoptosis in RB. And circ-0075804 positively regulated the expression of E2F3. Moreover, circ-0075804 facilitated cell proliferation and suppressed cell apoptosis. Besides, HNRNPK could bind with circ-0075804 in RB. Finally, knockdown of E2F3 partly rescued the promoting role of circ-0075804 overexpression in RB. Overall, circ-0075804 promotes the proliferation of RB via combining HNRNPK to improve the stability of E2F3, which brings new light for treating RB.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  E2F3; HNRNPK; circ-0075804; retinoblastoma

Mesh:

Substances:

Year:  2020        PMID: 32065448     DOI: 10.1002/jcb.29631

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression.

Authors:  Yanling Zhang; Xiaoyan Dou; Qinghui Kong; Yuying Li; Xing Zhou
Journal:  Int Ophthalmol       Date:  2021-10-11       Impact factor: 2.031

Review 2.  Regulatory Effects of Circular RNAs on Host Genes in Human Cancer.

Authors:  Xiong Wang; Huijun Li; Yanjun Lu; Liming Cheng
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

Review 3.  Circular RNA: metabolism, functions and interactions with proteins.

Authors:  Wei-Yi Zhou; Ze-Rong Cai; Jia Liu; De-Shen Wang; Huai-Qiang Ju; Rui-Hua Xu
Journal:  Mol Cancer       Date:  2020-12-14       Impact factor: 27.401

4.  circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3.

Authors:  Xiangjie Wang; Shuang Liu; Bin Xu; Yabin Liu; Peng Kong; Changlin Li; Binghui Li
Journal:  Anal Cell Pathol (Amst)       Date:  2021-10-08       Impact factor: 2.916

5.  hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis.

Authors:  Guangwei Jiang; Mingxuan Qu; Lili Kong; Xiaoming Song; Shanhao Jiang
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

6.  Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p.

Authors:  Zhe Sun; Ai Zhang; Mingyu Hou; Tao Jiang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

7.  Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.

Authors:  Bin Xu; Ning Yang; Yabin Liu; Peng Kong; Mei Han; Binghui Li
Journal:  Med Sci Monit       Date:  2020-08-28

8.  Circ_0000527 promotes osteosarcoma cell progression through modulating miR-646/ARL2 axis.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Lilin Shang
Journal:  Aging (Albany NY)       Date:  2021-02-22       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.